CURRICULUM VITAE. Informazioni personali

Transcript

1 CURRICULUM VITAE Informazioni personali Nome e Cognome FAUSTO ROSSINI Data di nascita 8/12/55 Qualifica DIRIGENTE MEDICO 1 LIVELLO Amministrazione Incarico attuale ematologo Numero telefonico ufficio Indirizzo istituzionale f.rossini@hsgerardo.org Titoli di studio e professionali ed esperienze lavorative Titolo di studio Specializzazione Esperienze professionali (incarichi ricoperti) Capacità linguistiche Capacità nell uso delle tecnologie Altro (partecipazione a convegni e seminari, pubblicazioni, collaborazioni a riviste, ecc., ed ogni altra informazione che il dirigente ritiene di dover pubblicare) LAUREA MEDICINA E CHIRURGIA EMATOLOGIA MEDICINA INTERNA PREVALENTE INTERESSAMENTO VERSO PATOLOGIE LINFOPROLIFERATIVE INGLESE INFORMATICA: GESTIONE DATABASE PRINCIPALI LAVORI SCIENTIFICI Scarfò L, Zibellini S, Tedeschi A, Maura F, Neri A, Bertazzoni P, Sarina B, Nalli G, Motta M, Rossini F, Cortelezzi A, Montillo M, Orlandi E, Ghia P. Impact of B-cell count and imaging screening in cmbl: any need to revise the current guidelines? Leukemia Jul;26(7): doi: /leu Epub 2012 Jan 30. No abstract available. Corso A, Galli M, Mangiacavalli S, Rossini F, Nozza A, Pascutto C, Montefusco V, Baldini L, Cafro AM, Crippa C, Cazzola M, Corradini P. Response-adjusted ISS (RaISS) is a simple and

2 reliable prognostic scoring system for predicting progression-free survival in transplanted patients with multiple myeloma. Am J Hematol Oct 14. doi: /ajh [Epub ahead of print] Cavallo F, Bringhen S, Milone G, Ben- Yehuda D, Nagler A, Calabrese E, Cascavilla N, Montefusco V, Lupo B, Liberati AM, Crippa C, Rossini F, Passera R, Patriarca F, Cafro AM, Omedè P, Carella AM, Peccatori J, Catalano L, Caravita T, Musto P, Petrucci MT, Boccadoro M, Palumbo A.: Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy. Leukemia Oct;25(10): doi: /leu Epub 2011 Jun 3. Mian M, Gaidano G, Conconi A, Tsang R, Gospodarowicz MK, Rambaldi A, Rossi A, Oldani E, Federico M, Luminari S, Bellei M, Pogliani EM, Rossini F, Cabrera ME, Martelli M, Lopez-Guillermo A, Busetto M, Cavalli F, Zucca E, Cortelazzo S. High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi study. Leuk Lymphoma May;52(5): Epub 2011 Feb 21 Mian M, Ferreri AJ, Rossi A, Conconi A, Tsang R, Gospodarowicz MK, Oldani E, Federico M, Luminari S, Pogliani EM, Rossini F, Cabrera ME, Martelli M, Gutierrez-Garcia G, Busetto M, Cavalli F, Zucca E, Rambaldi A, Cortelazzo S. Role of radiotherapy in patients with early-stage diffuse large B-cell lymphoma of Waldeyer's ring in remission after anthracycline-containing chemotherapy. Leuk Lymphoma Sep 6. [Epub ahead of print] Antonio Palumbo, Francesca Gay, Patrizia Falco, Claudia Crippa, Vittorio Montefusco, Francesca Patriarca, Fausto Rossini, et al; Bortezomib As Induction Before Autologous Transplantation, Followed by Lenalidomide As Consolidation-Maintenance in Untreated

3 Multiple Myeloma Patients. J Clin Oncol 28: (2010) Pagano L, Valentini CG, Posteraro B, Girmenia C, Ossi C, Pan A, Candoni A, Nosari A, Riva M, Cattaneo C, Rossini F, Fianchi L, Caira M, Sanguinetti M, Gesu GP, Lombardi G, Vianelli N et al; Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology).. J Chemother 21(3): (2009) Livio Pagano, Morena Caira, Anna Candoni, Massimo Offidani, Bruno Martino, Giorgina Specchia, Domenico Pastore, Marta Stanzani, Chiara Cattaneo, Rosa Fanci, Cecilia Caramatti, Fausto Rossini, et al; INVASIVE ASPERGILLOSIS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA: SEIFEM-2008 REGISTRY STUDY. Haematologica (2009) Lanzani F, Mattavelli L, Frigeni B, Rossini F, Cammarota S, Petrò D, Jann S, Cavaletti G.; Role of a pre-existing neuropathy on the course of bortezomibinduced peripheral neurotoxicity.. J Peripher Nerv Syst 13(4): (2008) F. Rossini; CLL. Management of complications: infections, autoimmunity, cytopenias. Hematology Meetings Report 7: 38 (2007) Pellegrino Musto, Fausto Rossini, Francesca Gay, Vincenzo Pitini, Tommasina Guglielmelli, Giovanni D Arena, Felicetto Ferrara, Nunzio Filardi, Roberto Guariglia, Antonio Palumbo, for the GISMM, GISL, and GIMEMA Cooperative Groups, Italy; Efficacy and Safety of Bortezomib in Patients With Plasma Cell Leukemia. Cancer (2007) Musto P, Scalzulli PR, Terruzzi E, Rossini F, Iacopino P, Messina G, Guariglia R, Pietrantuono G, Villani O, D'Auria F, Falcone A, Sanpaolo G,

4 Valvano MR, Pogliani EM, Morabito F; Peg-filgrastim versus filgrastim after autologous stem cell tranplantation: Case-control study in patients with multiple myeloma and review of the literature. Leuk Res. feb 22 (2007) Fausto Rossini, Enrico M. Pogliani. Il mieloma multiplo. Una guida pratica. Elsevier Antonio Palumbo, Sara Bringhen, Tommaso Caravita, Emanuela Merla, Vincenzo Capparella, Vincenzo Callea, Clotilde Cangialosi, Mariella Grasso, Fausto Rossini et al.; Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial. Lancet 367: (2006) Giampaolo Bucaneve, M.D., Alessandra Micozzi, M.D., Francesco Menichetti, for the Gruppo Italiano Malattie Ematologiche dell Adulto (GIMEMA) Infection Program*; Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia. NEJM 353: (2005) Fausto Rossini Elisabetta Terruzzi Luisa Verga Alessandra Larocca Sara Marinoni Isabella Miccolis Giuseppe Giltri Manuela Isella Matteo Parma Enrico M. Pogliani; A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia. Support Care Cancer 13: (2005) F. Rossini E.Terruzzi S. Cammarota F. Morini M. Fumagalli L.Verga E. Elli M.Verga I.Miccolis M. Parma E.M. Pogliani; Cytomegalovirus infection after autologous stemcell transplantation:incidence and outcome in a group of patients undergoing a surveillance program. Transpl Infect Dis 2005 : 7: 122^125 (2005) Antonio Palumbo, Sara Bringhen, Maria

5 Teresa Petrucci, Pellegrino Musto, Fausto Rossini, Martina Nunzi...Massimo Massaia, Franco Mandelli, Angelo Michele Carella, Enrico Pogliani.. Mario Boccadoro Cesare Bergonzi, Anna Barbui,; Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial. Blood 104: (2004) A Palumbo,, S Bringhen, A Bertola, F Cavallo, P Falco, M Massaia, B Bruno, C Rus, A Barbui, T Caravita, P Musto, N Pescosta, F Rossini, M Vignetti, M Boccadoro; Multiple myeloma: comparison of two dose-intensive melphalan regimens (100 vs 200 mg/sqm). Leukemia 18, (2004) F. Rossini, E. Terruzzi, D. Perego, I. Miccolis, F. Rivolta, E. Manca, E.M. Pogliani; Long-Term Follow-Up of Patients with Intermediate or High-Grade Non-Hodgkin Lymphoma Treated with a Combination of Cyclophosphamide, Epirubicin, Vincristine, and Prednisone. Cancer 100: (2004) E. M. Pogliani, F. Rossini, M. Verga, A. Larocca, L. Verga; Uso delle diverse formulazioni di amphotericina B nelle polmoniti del paziente neutropenico. L'Internista 9 (Suppl 1); 9-16 (2001) Enrico M. Pogliani, Fausto Rossini, Magda Verga, Isabella Miccolis, Viviana Sancassani, Gianmarco Corneo; Attualita' In Terapia Delle Micosi Profonde.analisi Della Letteratura E Studio Di Una Casistica Di 421 Polmoniti. L'Internista 2000; 8; (2000) F.Rossini, M.Verga, P.Pioltelli, G. Giltri, V. Sancassani, E.M.Pogliani, G. Corneo; Incidence And Outcome Of Pneumonia In Patients With Acute Leukemia Receiving First Induction Therapy With Anthracyclin-containing Regimens.. Haematologica 85: (2000) P. Lissoni, M. Mandalà, F. Rossini, L. Fumagalli, S. Barni; Thrombopoietic

6 propertiy of the pineal hormone melatonin. Hematology 4: (1999) F. Rossini, P. Pioltelli, S. Bolis, L. Borin, I. Casaroli, E. Lanzi, P. MaffÞ, M. Parma, P. Tripputi. E.M. Pogliani; Ceftriaxone/Amikacin vs Ceftazidime/Amikacin as Empirical Therapy for Fever in Patients with Haematological Malignancy and Severe Granulocytopenia. Clinical and Economic Outcomes. ClinIcal Drug Investigation 15 (5) (1998) E.M. Pogliani, F. Rossini, I. Casaroli, P. MaffÞ, G. Corneo; Thrombotic Complications in Acute Promyelocytic Leukemia during All- trans-retinoic Acid Therapy. Acta Haematologica 97: (1997) F. Rossini; Prognosis of infections in elderly patients with haematological diseases. Support Care Cancer 4: (1996) Enrico M. Pogliani, Giorgio Lambertenghi Deliliers, Luca Baldini, Anna Tosi, Chiara Butti, Ornella Chiorboli, Carlo Confalonieri, Sergio Fava, Maria Carla Giorgetti, Maurizio Maioli, Anna Teresa Maiolo,... Fausto Rossini, et al:; EBVD and alternating MOPP/EBVD with or without localized field radiotherapy in advanced or unfavourably presenting Hodgkin's disease.. Haematologica 81:8-14 (1996) P. Lissoni, G. Tancini, S. Barni, F. Paolorossi, F. Rossini, P. MaffÞ, L. Di Bella; The pineal hormone melatonin in hematology and its potential efficacy in the treatment of thombocytopenia. Recenti Progressi in Medicina 87: (1996) P. Lissoni, A. Ardizzoia, S. Barni, S. Pittalis, F. Rossini, A. Porta, G. Tancini; Characterization of cancer-related disseminated intravascular coagulation in relation to tumor necrosis facctor-alpha blood concentrations: possible

7 therapeutic role of pentoxifylline.. Tumori 82: (1996) P. Lissoni, S. Barni, F. Brivio, F. Rossini, L. Fumagalli, G. Tancini; Treatment of cancer-related thrombocytopenia by low-dose subcutaneous interleukin-2 plus pineal hormone melatonin: a biological phase II study. Journal of Biological Regulators and Homeostatic Agents 9: (1995) P. Tripputi, M. Minotti, F. Rossini, A. Gimmelli, P. Pioltelli, E. Lanzi, E.M. Pogliani, G. Corneo; B-Chronic lymphocytic leukemia and monoclonal lymphocytosis of undetermined significance: clinical features. Internal Medicine 3:95-98 (1995) E.M. Pogliani, F. Rossini, I. Miccolis, A. Ferrario, D. Perego, I.Casaroli, S. Bolis, D. Fagnani, M. Brambilla, G. Corneo; Alpha interferon as initial treatment of essential thrombocythemia. Analysis after two years of follow-up. Tumori 81: (1995) P. Lissoni, S. Barni, F. Brivio, F. Rossini, L. Fumagalli, A. Ardizzoia, G. Tancini; A biological study on the efficacy of low-dose subcutaneous Interleukin-2 plus Melatonin in the treatment of cancer-related thrombocytopenia. Oncology 52: (1995) E. R. Bregani, P. Lissoni, F. Rossini, S. Barni, G. Tancini, F. Brivio, A. Conti, G.J. Maestroni; Prevention of interleukin- 2-induced thrombocytopenia during the immunotherapy of cancer by a concomitant administration of the pineal hormone melatonin. Recenti Progressi in Medicina 86(6) (1995) F. Rossini, E.M. Pogliani, D. Perego, M. Brambilla, I. Casaroli, S. Bolis, A. Ferrario, D. Fagnani, E. Negretti, S. Banducci, A. Urso, G. Corneo; Short term, induction therapy with VBCMP alternating with alfa interferon for induction therapy of advanced stages of multiple myeloma in patients younger

8 than 70. Internal Medicine 3: (1995) S. Bolis, E.R. Bregani, F. Rossini, I. Casaroli, E. Lanzi, P. Maffe', L. Baldicchi, L. Borin, S. Mingozzi, P. Tripputi, E.M. Pogliani, G. Corneo; Advances in staging and therapy of multiple myeloma. Recenti Progressi in Medicina 85(1): (1994) F. Rossini, P. Pioltelli, S. Mingozzi, R. Bregani, F. Vigano', S. Bolis, I. Casaroli, E. Lanzi, E. Pogliani, G. Corneo; Amikacin and ceftazidime as empirical antibiotic therapy in severely neutropenic patients: analysis of prognostic factors. Supportive Care Cancer 2: (1994) P. Lissoni, M. Cazzaniga, A. Ardizzoia, F. Rossini, G. Fiorelli, G. Tancini, S. Pittalis, S. Barni; Cytokine regulation of iron metabolism: effect of low-dose interleukin-2 subcutaneous therapy on ferritin, transferrin and iron blood concentrations in cancer patients. Journal of Biological Regulators and Homeostatic Agents 7(1):31-33 (1993) S. Bolis, E. R. Bregani, F. Rossini, R. Schiavina, E.M. Pogliani; Atrial Flutter followed by sick sinus syndrome as presenting symptoms of B-cell malignant non- Hodgkin lymphoma involving the heart. Haematolgica 78: (1993) P. Lissoni, A. Ardizzoia, E. Tisi, F. Rossini, S. Barni, G. Tancini, A. Conti, G.J.M. Maestroni; Amplification of eosinophilia by melatonin during the immunotherapy of cancer with interleukin-2. Journal of Biological Regulators and Homeostatic Agents 7(1):34-36 (1993) F. Rossini, F. Brivio, S. Mingozzi, P. Lissoni, P. Pioltelli; Thrombocytosis, neutrophilia and anemia during interleukin-2 therapy. Haematologica 76:439 (1991)

9 F. Rossini, S. Mingozzi, E.M. Pogliani, P. Pioltelli, E. Lanzi, G. Corneo; NHL of the elderly. Prognostic factors and outcome. Recenti progressi in medicina 82: (1991) P. Pioltelli, L. Baldicchi, A. Ferrario, F. Rossini, E. Lanzi, E. Pogliani, G. Corneo; Considerazioni sulla evoluzione clinica delle anemie refrattarie. Studio di una casistica di 56 casi. La Clinica Terapeutica 137: (1991) F. Rossini, E.M. Pogliani, P. Pioltelli, E. Lanzi, I. Casaroli, S. Bolis, G. Corneo; Surgery and chemotherapy in the treatment of gastric non-hodgkin's lymphoma.. Recenti Progressi in Medicina 81, 6, 448 (1990) F. Rossini, P. Pioltelli, E. Lanzi, I. Casaroli, S. Bolis, E.M. Pogliani, G. Corneo; I linfomi non-hodgkin: stadiazione e terapia. La Clinica Terapeutica 128; (1989) E.M. Pogliani, F. Arienti, P. Pioltelli, F. Rossini, E. Lanzi, G. Corneo; L'impiego della timomodulina nei pazienti con linfoma di Hodgkin in corso di terapia antiblastica. Progr Oncol Clin 2 (Suppl 1) (1988) E.M. Pogliani, C. Fowst, P. Pioltelli, E. Lanzi, F. Rossini, G. Corneo; Hypomagnesemic hypocalcemia in non- Hodgkin's lymphoma. Current Therapeutic Research 44, 5 (1988) E.M. Pogliani,P. Pioltelli, F. Rossini, E. Lanzi, G. Corneo; Acute leukemia following Cisplatin for ovarian cancer.. Haematologica 72: (1987) M. Galli, G. Ortisi, A.M. Fiorenza, F. Rossini, A. Lelli, C. Zanussi; Valutazione clinica della cefoxitina somministrata per via parenterale nel trattamento di infezioni batteriche acute in pazienti ospedalizzati.. The European Journal of Chemotherapy and antibiotics 1:41-46 (1981)

10